Posted by Michael Wonder on 27 Jul 2023
Molnupiravir will remain available for people who need it
27 July 2023 - PHARMAC has confirmed today that molnupiravir will remain available as a treatment to protect against infection from COVID-19 for people who need it.
In April 2023, PHARMAC sought feedback on the funding of molnupiravir as evolving evidence suggested it may no longer be as effective compared to what had been considered previously.
